Saamya Biotech IPO Latest News Today

Saamya Biotech India Limited IPO listing info:

IPO Listing Date: Friday, October 19, 2007
BSE Script Code: 532905
Listing in: B1 Group
ISIN: INE320H01019
Issue Price: Rs 10/- Per Equity Share
Face Value : Rs 10/- Per Equity Share

IPO Allotment Status is now available online for Saamya Biotech India Limited.

Saamya Biotech India Limited IPO was closed on September 28, 2007.

 

Saamya Biotech India Limited IPO listing info:

IPO Listing Date: Friday, October 19, 2007
BSE Script Code: 532905
Listing in: B1 Group
ISIN: INE320H01019
Issue Price: Rs 10/- Per Equity Share
Face Value : Rs 10/- Per Equity Share

IPO Allotment Status is now available online for Saamya Biotech India Limited.

Saamya Biotech India Limited IPO was closed on September 28, 2007.

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.

The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.

The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.
 
The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).